Cargando…

Three-hour analysis of non-invasive foetal sex determination: application of Plexor chemistry

BACKGROUND: The knowledge of the individual genetic “status” in the prenatal era is particularly relevant in the case of positive family history for genetic diseases, in advanced maternal age and in the general screening for foetal abnormalities. In this context, here, we report an innovative molecu...

Descripción completa

Detalles Bibliográficos
Autores principales: Pietropolli, Adalgisa, Capogna, Maria Vittoria, Cascella, Raffaella, Germani, Chiara, Bruno, Valentina, Strafella, Claudia, Sarta, Simona, Ticconi, Carlo, Marmo, Giusy, Gallaro, Sara, Longo, Giuliana, Marsella, Luigi Tonino, Novelli, Antonio, Novelli, Giuseppe, Piccione, Emilio, Giardina, Emiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820952/
https://www.ncbi.nlm.nih.gov/pubmed/27044517
http://dx.doi.org/10.1186/s40246-016-0066-2
_version_ 1782425504146522112
author Pietropolli, Adalgisa
Capogna, Maria Vittoria
Cascella, Raffaella
Germani, Chiara
Bruno, Valentina
Strafella, Claudia
Sarta, Simona
Ticconi, Carlo
Marmo, Giusy
Gallaro, Sara
Longo, Giuliana
Marsella, Luigi Tonino
Novelli, Antonio
Novelli, Giuseppe
Piccione, Emilio
Giardina, Emiliano
author_facet Pietropolli, Adalgisa
Capogna, Maria Vittoria
Cascella, Raffaella
Germani, Chiara
Bruno, Valentina
Strafella, Claudia
Sarta, Simona
Ticconi, Carlo
Marmo, Giusy
Gallaro, Sara
Longo, Giuliana
Marsella, Luigi Tonino
Novelli, Antonio
Novelli, Giuseppe
Piccione, Emilio
Giardina, Emiliano
author_sort Pietropolli, Adalgisa
collection PubMed
description BACKGROUND: The knowledge of the individual genetic “status” in the prenatal era is particularly relevant in the case of positive family history for genetic diseases, in advanced maternal age and in the general screening for foetal abnormalities. In this context, here, we report an innovative molecular assay which utilizes the cell-free foetal DNA (cffDNA) as a source for the early and fast detection of the foetal sex. The study involved 132 pregnant women in their first 3 months of pregnancy, who agreed to give a blood sample. All the collected samples were immediately subjected to the separation of the plasma, which was utilized for the extraction of the cffDNA. Successively, the extracted cffDNA was analysed by a quantitative PCR (qPCR) method based on Plexor-HY chemistry, which is able to simultaneously identify, quantify and discriminate the autosomal DNA from the sex-linked DNA. RESULTS: Overall, the Plexor-HY assay demonstrated to be sensitive and specific for the determination of low-template DNA, such as the cffDNA. In fact, the Plexor-HY assay has been successfully performed in all the samples, identifying 70 males and 62 females. As the foetal sex can be provided in 120 min just by utilizing a maternal blood sample as cffDNA source, the assay represents a very fast, safe and non-invasive prenatal method. CONCLUSIONS: The possibility of determining the foetal sex in the early prenatal life consents the application of our assay as a helpful screening test for subjects and families at risk of sex-linked disorders. Moreover, the early knowledge of the foetal sex may be of great help even for the specialist, who might promptly advise the patients concerning the foetal risk of inheriting sex-linked disorders and the clinical utility of performing an invasive prenatal diagnosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40246-016-0066-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4820952
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48209522016-04-06 Three-hour analysis of non-invasive foetal sex determination: application of Plexor chemistry Pietropolli, Adalgisa Capogna, Maria Vittoria Cascella, Raffaella Germani, Chiara Bruno, Valentina Strafella, Claudia Sarta, Simona Ticconi, Carlo Marmo, Giusy Gallaro, Sara Longo, Giuliana Marsella, Luigi Tonino Novelli, Antonio Novelli, Giuseppe Piccione, Emilio Giardina, Emiliano Hum Genomics Letter to the Editor BACKGROUND: The knowledge of the individual genetic “status” in the prenatal era is particularly relevant in the case of positive family history for genetic diseases, in advanced maternal age and in the general screening for foetal abnormalities. In this context, here, we report an innovative molecular assay which utilizes the cell-free foetal DNA (cffDNA) as a source for the early and fast detection of the foetal sex. The study involved 132 pregnant women in their first 3 months of pregnancy, who agreed to give a blood sample. All the collected samples were immediately subjected to the separation of the plasma, which was utilized for the extraction of the cffDNA. Successively, the extracted cffDNA was analysed by a quantitative PCR (qPCR) method based on Plexor-HY chemistry, which is able to simultaneously identify, quantify and discriminate the autosomal DNA from the sex-linked DNA. RESULTS: Overall, the Plexor-HY assay demonstrated to be sensitive and specific for the determination of low-template DNA, such as the cffDNA. In fact, the Plexor-HY assay has been successfully performed in all the samples, identifying 70 males and 62 females. As the foetal sex can be provided in 120 min just by utilizing a maternal blood sample as cffDNA source, the assay represents a very fast, safe and non-invasive prenatal method. CONCLUSIONS: The possibility of determining the foetal sex in the early prenatal life consents the application of our assay as a helpful screening test for subjects and families at risk of sex-linked disorders. Moreover, the early knowledge of the foetal sex may be of great help even for the specialist, who might promptly advise the patients concerning the foetal risk of inheriting sex-linked disorders and the clinical utility of performing an invasive prenatal diagnosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40246-016-0066-2) contains supplementary material, which is available to authorized users. BioMed Central 2016-04-04 /pmc/articles/PMC4820952/ /pubmed/27044517 http://dx.doi.org/10.1186/s40246-016-0066-2 Text en © Pietropolli et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter to the Editor
Pietropolli, Adalgisa
Capogna, Maria Vittoria
Cascella, Raffaella
Germani, Chiara
Bruno, Valentina
Strafella, Claudia
Sarta, Simona
Ticconi, Carlo
Marmo, Giusy
Gallaro, Sara
Longo, Giuliana
Marsella, Luigi Tonino
Novelli, Antonio
Novelli, Giuseppe
Piccione, Emilio
Giardina, Emiliano
Three-hour analysis of non-invasive foetal sex determination: application of Plexor chemistry
title Three-hour analysis of non-invasive foetal sex determination: application of Plexor chemistry
title_full Three-hour analysis of non-invasive foetal sex determination: application of Plexor chemistry
title_fullStr Three-hour analysis of non-invasive foetal sex determination: application of Plexor chemistry
title_full_unstemmed Three-hour analysis of non-invasive foetal sex determination: application of Plexor chemistry
title_short Three-hour analysis of non-invasive foetal sex determination: application of Plexor chemistry
title_sort three-hour analysis of non-invasive foetal sex determination: application of plexor chemistry
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820952/
https://www.ncbi.nlm.nih.gov/pubmed/27044517
http://dx.doi.org/10.1186/s40246-016-0066-2
work_keys_str_mv AT pietropolliadalgisa threehouranalysisofnoninvasivefoetalsexdeterminationapplicationofplexorchemistry
AT capognamariavittoria threehouranalysisofnoninvasivefoetalsexdeterminationapplicationofplexorchemistry
AT cascellaraffaella threehouranalysisofnoninvasivefoetalsexdeterminationapplicationofplexorchemistry
AT germanichiara threehouranalysisofnoninvasivefoetalsexdeterminationapplicationofplexorchemistry
AT brunovalentina threehouranalysisofnoninvasivefoetalsexdeterminationapplicationofplexorchemistry
AT strafellaclaudia threehouranalysisofnoninvasivefoetalsexdeterminationapplicationofplexorchemistry
AT sartasimona threehouranalysisofnoninvasivefoetalsexdeterminationapplicationofplexorchemistry
AT ticconicarlo threehouranalysisofnoninvasivefoetalsexdeterminationapplicationofplexorchemistry
AT marmogiusy threehouranalysisofnoninvasivefoetalsexdeterminationapplicationofplexorchemistry
AT gallarosara threehouranalysisofnoninvasivefoetalsexdeterminationapplicationofplexorchemistry
AT longogiuliana threehouranalysisofnoninvasivefoetalsexdeterminationapplicationofplexorchemistry
AT marsellaluigitonino threehouranalysisofnoninvasivefoetalsexdeterminationapplicationofplexorchemistry
AT novelliantonio threehouranalysisofnoninvasivefoetalsexdeterminationapplicationofplexorchemistry
AT novelligiuseppe threehouranalysisofnoninvasivefoetalsexdeterminationapplicationofplexorchemistry
AT piccioneemilio threehouranalysisofnoninvasivefoetalsexdeterminationapplicationofplexorchemistry
AT giardinaemiliano threehouranalysisofnoninvasivefoetalsexdeterminationapplicationofplexorchemistry